Shin Hyun-young, AstraZeneca’s’stability’ allegedly’one-third of vaccines in major countries’

“The US also has only 20% of Pfizer and Moderna”

Shin Hyun-young, Democratic Party lawmaker / Yonhap News

On the 24th, Democratic Party lawmaker Shin Hyun-young said, “One of the three corona vaccines in 12 major countries is AstraZeneca.” When some recently raised a question about’vaccine stability’ about the government’s intensive securing of AstraZeneca vaccine, the ruling party raised the status of advanced countries.

Congressman Shin said on the day, “According to the data submitted by the Ministry of Health and Welfare, the corona vaccine obtained in 12 countries including the United States amounted to about 5,060 million doses, of which AstraZeneca vaccine accounted for 36.6% (1.85 billion doses) the most. “He said. According to Congressman Shin’s claim, AstraZeneca accounted for the largest share of 1.85 billion doses (36.6%) of vaccines secured by 12 countries including the US, EU, UK, Japan, and Canada on the 4th of this month. In particular, it is reported that the US contracted 500 million doses (49.5%) of the AstraZeneca vaccine, accounting for half of the domestic volume.

Regarding the controversy about securing a vaccine that continues in politics, Congressman Shin admitted that it would have been good to have secured Pfizer, Moder, or vaccine a little earlier. It can be said that there is a reasonable basis for the government’s judgment secured.” He continued, “If you look at the current status of securing vaccines in major countries around the world, you can see that not only us but also other countries are making similar judgments and preparations.”

Rep. Shin also said, “The US, which first approved Pfizer and Modena vaccines and started vaccinating them, accounts for 20% of the total amount of vaccines obtained by Pfizer and Modena vaccines. The vaccine was approved first, but it seems to be because the actual production is limited.”
/ Reporter Hyein Lee [email protected]

< 저작권자 ⓒ 서울경제, 무단 전재 및 재배포 금지 >

Source